This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- 18F-FDG PET Is an Independent Outcome Predictor in Primary Central Nervous System Lymphoma
- Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies
- Role of Positron Emission Tomography in Lymphoma
- PET Scans in the Staging of Lymphoma: Current Status
- Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant Lymphoma
- Ki-67 Immunostaining in Pancreatic Cancer and Chronic Active Pancreatitis: Does In Vivo FDG Uptake Correlate with Proliferative Activity?
- Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
- Glucose Metabolism of Breast Cancer Assessed by 18F-FDG PET: Histologic and Immunohistochemical Tissue Analysis
- Lung Cancer Proliferation Correlates with [F-18]Fluorodeoxyglucose Uptake by Positron Emission Tomography
- Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography